RE:ExpereoI bot CXR soon after the RTO at $6. I've traded around my position always
keeping a core position
Currently long several thousand shares and will prob add to that in the event
that an offer does not materialize in the near term and the share price retreats.
The stock is extremely undervalued as many on this board are aware. Debt, while
hi, is manageable out of Cashflow which is also on the rise. Debt levels will be paid down
out of a rising cashflow equals huge leverage to earnings.
These drugs have extremely long tails so the risk of the portfolio declining in any meaningful
way is diminimus. New products coming on with addition of access to new markets over the
next few years.
The management strategy which is one of rinse, wash and repeat has been employed in Calgary
by numerous management teams whom I am keenly familiar with.